Regeneron tapped for COVID-19 antibody cocktail


RENSSELAER, N.Y. (NEWS10) — The federal government is working to fast track a vaccine and treatment for COVID-19 dubbed Operation Warp Speed, and it’s tapping some of the nation’s best biotech and pharmaceutical companies to try to do it.

In the Capital Region, Regeneron has been awarded a $450 million contract to manufacture and supply a double antibody coronavirus cocktail.

It’s currently in Phase 2 of three clinical trials for treatment of COVID-19, and Phase 3 of trials of the prevention of COVID-19 infection.

County-by-county Coronavirus Tracker
Watch Updates from Officials
COVID-19 Resources
Reopening New York
More Coronavirus Coverage from News10


Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Click Below to set up your cable box

No Neighbor Hungry Campaign

Download our news app

App Store Link
Google Play Link

Coronavirus Outbreak

More Coronavirus Outbreak

Classroom Progress Report

More Classroom Progress Report

10 in Toga